- Home
- ESAB vs CRL Comparison
ESAB vs CRL Comparison
Compare ESAB & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESAB
- CRL
- Stock Information
- Founded
- ESAB 1904
- CRL 1947
- Country
- ESAB United States
- CRL United States
- Employees
- ESAB N/A
- CRL N/A
- Industry
- ESAB Office Equipment/Supplies/Services
- CRL Biotechnology: Commercial Physical & Biological Resarch
- Sector
- ESAB Industrials
- CRL Health Care
- Exchange
- ESAB Nasdaq
- CRL Nasdaq
- Market Cap
- ESAB 7.8B
- CRL 6.8B
- IPO Year
- ESAB N/A
- CRL 2000
- Fundamental
- Price
- ESAB $115.59
- CRL $147.44
- Analyst Decision
- ESAB Buy
- CRL Hold
- Analyst Count
- ESAB 8
- CRL 15
- Target Price
- ESAB $136.50
- CRL $186.38
- AVG Volume (30 Days)
- ESAB 251.0K
- CRL 764.6K
- Earning Date
- ESAB 08-01-2025
- CRL 08-06-2025
- Dividend Yield
- ESAB 0.35%
- CRL N/A
- EPS Growth
- ESAB 16.34
- CRL N/A
- EPS
- ESAB 4.43
- CRL N/A
- Revenue
- ESAB $2,729,197,000.00
- CRL $4,022,597,000.00
- Revenue This Year
- ESAB N/A
- CRL N/A
- Revenue Next Year
- ESAB $5.55
- CRL $2.47
- P/E Ratio
- ESAB $25.96
- CRL N/A
- Revenue Growth
- ESAB N/A
- CRL N/A
- 52 Week Low
- ESAB $88.54
- CRL $91.86
- 52 Week High
- ESAB $135.97
- CRL $254.15
- Technical
- Relative Strength Index (RSI)
- ESAB 31.39
- CRL 57.46
- Support Level
- ESAB $122.83
- CRL $143.06
- Resistance Level
- ESAB $125.95
- CRL $154.43
- Average True Range (ATR)
- ESAB 2.65
- CRL 4.61
- MACD
- ESAB -1.20
- CRL -0.18
- Stochastic Oscillator
- ESAB 8.12
- CRL 68.01
About ESAB ESAB Corporation
ESAB, spun off from Colfax in 2022, is a leading manufacturer of equipment and consumables used in welding, cutting, and joining applications. Alongside competitors Lincoln Electric and ITW's Miller brand, ESAB is one of the top three players in the welding space. ESAB generated roughly $2.7 billion in revenue in 2024.
About CRL Charles River Laboratories International Inc.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.